ADvantage Therapeutics

ADvantage Therapeutics GmbH founded in 2021 is the Vienna BioCenter-based subsidiary of ADvantage Therapeutics, Inc., a Delaware corporation having offices in Miami (FL), USA. ADvantage is developing therapies to treat neurodegenerative conditions like Alzheimer’s disease (AD) and is currently preparing for clinical trials in Europe and in the US. Furthermore, ADvantage is developing new therapies to treat AD in its labs at the Vienna BioCenter.